[1]
B. Tekieli, “GLP-1 AND DUAL GLP-1/GIP RECEPTOR AGONISTS AS NEUROPROTECTIVE AGENTS: MECHANISMS, CLINICAL EVIDENCE, AND TRANSLATIONAL PERSPECTIVES”, IJITSS, vol. 4, no. 3(51), Sep. 2026, doi: 10.31435/ijitss.3(51).2026.6110.